The Assessment Approach of Frailty May Influence Its Prognostic Impact Amidst Clinical Trials.

CHIA-TER CHAO2025-09-122025-09-122025-07-04https://scholars.lib.ntu.edu.tw/handle/123456789/732015endiabetes mellitusfrail phenotypefrailtysodium‐glucose cotransporter 2 inhibitor[SDGs]SDG2[SDGs]SDG3[SDGs]SDG5The Assessment Approach of Frailty May Influence Its Prognostic Impact Amidst Clinical Trials.letter10.1111/jgs.1959640614066